SBTi targets validated for Wellspect HealthCare
Guided by its sustainability strategy “BEYOND: Taking action for a brighter world”,Dentsply Sirona has shown great determination over the years to drive improvements throughout its business to advance with confidence towards a more sustainable future. As part of this comittment, its Wellspect HealthCare business has set ambitious greenhouse gas emission reduction targets.
Charlotte, N.C., April 23, 2024. Dentsply Sirona, the world’s largest manufacturer of professional dental products and technologies and provider of continence care solutions, has announced that its Wellspect HealthCare business has received validation of its emission reduction targets from the Science Based Targets initiative (SBTi). The validation confirms that the greenhouse gas (GHG) emission reduction targets submitted by Wellspect HealthCare comply with the SBTi criteria and align with the 1.5°C trajectory.
The SBTi has commended Wellspect for its ambitious net-zero target, currently the most ambitious designation available through the SBTi process. To date, around 8,000 companies worldwide have set science based-targets, although less than half have net-zero targets in place.
“I am incredibly proud of our Wellspect HealthCare team and the impressive strides they have made to further sustainability. The entire Dentsply Sirona organization is committed to continuing to drive toward our broad ESG goals. By defining ambitious goals, we set the course towards real change and creating a measurable positive impact for our employees, customers, communities, our industry and the planet,” said Tony Johnson, SVP, Chief Supply Chain Officer and Head of Sustainability at Dentsply Sirona.
Dedication to sustainability across the company validated by results
Since formalizing its “BEYOND. Taking action for a brighter world” strategy in 2021,Dentsply Sirona has demonstrated its dedication to sustainability by making solid progress against its goals. In fact, with a view to Scope 1 and 2 GHG emission intensity and water withdrawal intensity, the company achieved its reduction goals ahead of the original 2025 timeframe and is in the process of setting new near-term goals for 2030, in support of the company’s 2050 net-zero goal. In recognition of Dentsply Sirona’s progress and based on GIST impact data, the company was recently named one of “America’s top 300 Greenest Companies in 2024” by Newsweek magazine.
“We aspire to be a force of positive change and are well positioned to become sustainability leaders in our industry. By leveraging today’s technologies and industry know-how, we can produce a new generation of medical devices that provide more sustainable options for health care professionals and for end-product users. It is a win-win for everyone”, says Chris Schlenk, Group Vice President at Wellspect HealthCare.
Outline of Wellspect HealthCare’s Science-Based Targets
Overall Net-Zero Target: Wellspect commits to reach net-zero GHG emissions across the value chain by 2045.
Near-Term Targets: Wellspect commits to reduce absolute scope 1 and 2 GHG emissions by 80% by 2030 from a 2021 base year* as well as absolute scope 3 GHG emissions covering upstream transportation and distribution, waste generated in operations and upstream leased assets with 42% within the same timeframe.
Wellspect further commits that 74.9% of its suppliers by emissions covering purchased goods and services, capital goods and upstream transportation and distribution will have sciencebased targets by 2026**.
* The target boundary includes biogenic land-related emissions and removals from bioenergy feedstocks.Long-Term Targets Wellspect AB commits to reduce absolute scope 1 and 2 GHG emission 95% by 2045 from a 2021 base year*. Wellspect AB also commits to reduce absolute scope 3 GHG emissions 90% within the same timeframe.
**The target boundary includes biogenic land-related emissions and removals from bioenergy feedstocks.
About the Science Based Targets initiative
The Science Based Targets initiative (SBTi) is a global body enabling businesses to set ambitious emissions reductions targets in line with the latest climate science. It is focused on accelerating companies across the world to halve emissions before 2030 and achieve net-zero emissions before 2050. The initiative is a collaboration between CDP, the United Nations Global Compact, World Resources Institute (WRI), the World Wide Fund for Nature (WWF) and one of the We Mean Business Coalition commitments. The SBTi defines and promotes best practice in science-based target setting and independently assesses companies’ targets.
Press Contact
Marion Par-Weixlberger | Vice President Public Relations & Corporate Communications
Sirona Straße 1 | 5071 Wals bei Salzburg | Austria
T +43 (0) 662 2450-588 | F +43 (0) 662 2450-540
marion.par-weixlberger@dentsplysirona.com | www.dentsplysirona.com
About Wellspect HealthCare
Wellspect HealthCare is a subsidiary of Dentsply Sirona and is a leading global provider of innovative medical devices that help people suffering from urinary retention or chronic constipation. More than 1,000 employees around the world are dedicated to making a difference to people who need our products and services. Wellspect is one of the worlds’ leading manufacturers of intermittent urinary catheters, with LoFric® as the most known brand. As a help to those with chronic or severe constipation Wellspect has developed what likely is the world’s most advanced irrigation system, Navina™, combining a high degree of user convenience, clinical effectiveness and connectivity into one smart system. Wellspect strives to become climate neutral and leave the smallest possible environmental footprint. Wellspect is headquartered in Mölndal, Sweden and is present in more than 30 countries. Dentsply Sirona is the worlds´ largest manufacturer of professional dental technologies. Dentsply Sirona’s shares are listed in the United States on NASDAQ under the symbol XRAY.
Tags:
